Decision (EU, Euratom) 2023/1895 of the European Parliament of 10 May 2023 on discharge in respect of the implementation of the budget of the European Medicines Agency (EMA) for the financial year 2021
Date: 2023-05-10
Institutions: European Parliament
Subjects: European Medicines Agency, budgetary discharge, financial year, general budget (EU)








L_2023242EN.01033401.xml










29.9.2023   


EN


Official Journal of the European Union


L 242/334








            DECISION (EU, Euratom) 2023/1895 OF THE EUROPEAN PARLIAMENT
         
of 10 May 2023
         
on discharge in respect of the implementation of the budget of the European Medicines Agency (EMA) for the financial year 2021


THE EUROPEAN PARLIAMENT,







—


having regard to the final annual accounts of the European Medicines Agency for the financial year 2021,










—


having regard to the Court of Auditors’ annual report on EU agencies for the financial year 2021, together with the agencies’ replies (1),










—


having regard to the statement of assurance (2) as to the reliability of the accounts and the legality and regularity of the underlying transactions provided by the Court of Auditors for the financial year 2021, pursuant to Article 287 of the Treaty on the Functioning of the European Union,










—


having regard to the Council’s recommendation of 28 February 2023 on discharge to be given to the Agency in respect of the implementation of the budget for the financial year 2021 (06248/2023 – C9-0091/2023),










—


having regard to Article 319 of the Treaty on the Functioning of the European Union,










—


having regard to Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council of 18 July 2018 on the financial rules applicable to the general budget of the Union, amending Regulations (EU) No 1296/2013, (EU) No 1301/2013, (EU) No 1303/2013, (EU) No 1304/2013, (EU) No 1309/2013, (EU) No 1316/2013, (EU) No 223/2014, (EU) No 283/2014, and Decision No 541/2014/EU and repealing Regulation (EU, Euratom) No 966/2012 (3), and in particular Article 70 thereof,










—


having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing a European Medicines Agency (4), and in particular Article 68 thereof,










—


having regard to Commission Delegated Regulation (EU) 2019/715 of 18 December 2018 on the framework financial regulation for the bodies set up under the TFEU and Euratom Treaty and referred to in Article 70 of Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council (5), and in particular Article 105 thereof,










—


having regard to Rule 100 of and Annex V to its Rules of Procedure,










—


having regard to the opinion of the Committee on the Environment, Public Health and Food Safety,










—


having regard to the report of the Committee on Budgetary Control (A9-0106/2023),













1.


Grants the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency’s budget for the financial year 2021;










2.


Sets out its observations in the resolution below;










3.


Instructs its President to forward this decision, and the resolution forming an integral part of it, to the Executive Director of the European Medicines Agency, the Council, the Commission and the Court of Auditors, and to arrange for their publication in the Official Journal of the European Union (L series).









The President

Roberta METSOLA
            



The Secretary-General

Alessandro CHIOCCHETTI
            





(1)  
            OJ C 412, 27.10.2022, p. 12.

(2)  
            OJ C 399, 17.10.2022, p. 240.

(3)  
            OJ L 193, 30.7.2018, p. 1.

(4)  
            OJ L 136, 30.4.2004, p. 1.

(5)  
            OJ L 122, 10.5.2019, p. 1.